Pfizer News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

23.05.18	FDA Grants Breakthrough Therapy Designation for Tafamidis for the Treatment of Patients with Transthyretin Cardiomyopathy (Businesswire)
22.05.18	A Study Analyzing Observational Data Shows Real-World Effectiveness of Prevnar® 13 in Adults Age 65+ (Businesswire)
22.05.18	Pfizer Begins Phase 1/2 Study To Evaluate Respiratory Syncytial Virus Vaccine (RTTNews)
22.05.18	Pfizer Begins a Phase 1/2 Study to Evaluate Respiratory Syncytial Virus (RSV) Vaccine (Businesswire)
21.05.18	GlaxoSmithKline Reports EU Marketing Authorisation For Juluca To Treat HIV (RTTNews)
17.05.18	Pfizer: Lyrica Oral Solution CV Phase 3 Trial Meets Primary Endpoint (RTTNews)
17.05.18	LYRICA® (pregabalin) Oral Solution CV Phase 3 Trial in Pediatric Epilepsy Meets Primary Endpoint (Businesswire)
16.05.18	Pfizer Oncology to Showcase Clinical Advances from its Growing Portfolio and Research Pipeline at ASCO (Businesswire)
16.05.18	LLY Gets Headache Relief, XENE Abuzz, 3rd Time's A Charm For PFE's Epogen Biosim (RTTNews)
16.05.18	Pfizer : FDA Oks First Epoetin Alfa Biosimilar For Treatment Of Anemia (RTTNews)
15.05.18	Pfizer’s Biosimilar RETACRIT® (epoetin alfa-epbx) Approved by U.S. FDA (Businesswire)
03.05.18	AKAO Slumps On FDA Panel Vote, ESPR Awaits Data In May, STAA Shines (RTTNews)
01.05.18	Merck And Pfizer Q1 Adj. Profit Tops View, But Sales Miss (RTTNews)
01.05.18	Pfizer Inc. Q1 adjusted earnings Beat Estimates (RTTNews)
01.05.18	PFIZER REPORTS FIRST-QUARTER 2018 RESULTS (Businesswire)
26.04.18	Pfizer Hosts Annual Meeting of Shareholders (Businesswire)
24.04.18	Modern Miracles: America's 10 Best-Selling Drugs (RTTNews)
24.04.18	PRTA Jolted, FDA Strikes Down PFE's Herceptin Biosimilar, No Relief Yet For KMDA (RTTNews)
23.04.18	Pfizer: FDA Grants Trumenba Breakthrough Therapy Designation (RTTNews)
23.04.18	Pfizer Granted FDA Breakthrough Therapy Designation for TRUMENBA® (Meningococcal Group B Vaccine) for the Prevention of Invasive Meningococcal B Disease in Children Ages 1 to 9 Years (Businesswire)
23.04.18	Pfizer: EU Approves Mylotarg In Combination With Chemotherapy To Treat AML (RTTNews)
23.04.18	Pfizer Receives CRL On Trastuzumab Biosimilar (RTTNews)
23.04.18	Pfizer Provides Update on Proposed Trastuzumab Biosimilar (Businesswire)
23.04.18	MYLOTARG™ Approved In The EU For The Treatment Of Previously Untreated, De Novo, CD33-positive Acute Myeloid Leukemia In Combination With Chemotherapy (Businesswire)
19.04.18	Pfizer Invites Public to Listen to Webcast of April 26 Annual Meeting of Shareholders (Businesswire)
13.04.18	FDA Nod For Innovus' Kit, PLSE Soars On SK Data, Keep An Eye On ARNA (RTTNews)
12.04.18	Pfizer Begins Clinical Trial With Mini-dystrophin Gene Therapy Candidate (RTTNews)
12.04.18	Pfizer Doses First Patient Using Investigational Mini-Dystrophin Gene Therapy for the Treatment of Duchenne Muscular Dystrophy (Businesswire)
11.04.18	AGTC Awaits Gene Therapy Data, FDA Delays Decision On Elagolix, KPTI On Watch (RTTNews)
10.04.18	Pfizer Provides Update on Phase 3 Trial of Axitinib as Adjuvant Treatment for Patients at High Risk of Renal Cell Carcinoma Recurrence After Surgery (Businesswire)
10.04.18	Pfizer Signs Lease for the Spiral at Hudson Yards in Manhattan (Businesswire)
06.04.18	A Glance At Potential Therapies For Sickle Cell Disease (RTTNews)
04.04.18	Pfizer: FDA Grants Priority Review For Dacomitinib - Quick Facts (RTTNews)
04.04.18	U.S. FDA and European Medicines Agency Accept Regulatory Submissions for Review of Dacomitinib to Treat Metastatic Non-Small Cell Lung Cancer with EGFR-Activating Mutations (Businesswire)
04.04.18	Pfizer Reportedly In Talks With P&G On Consumer Business Sale (RTTNews)
03.04.18	Cellectis, Allogene To Continue Strategic Cancer Immunotherapy Collaboration (RTTNews)
03.04.18	Pfizer To Hold 25% Ownership Stake In Allogene Therapeutics (RTTNews)
03.04.18	Pfizer and Allogene Therapeutics Enter into Asset Contribution Agreement for Pfizer’s Allogeneic CAR T Immuno-oncology Portfolio (Businesswire)
03.04.18	Will These Drugs Reach Blockbuster Status? (RTTNews)
29.03.18	Pfizer Reports Positive Results From Phase 3 ATTR-ACT Study Of Tafamidis (RTTNews)
29.03.18	Pfizer Announces Positive Topline Results From Phase 3 ATTR-ACT Study Of Tafamidis In Patients With Transthyretin Cardiomyopathy (Businesswire)
23.03.18	Sandoz: CHMP Adopts Positive Opinion For Infliximab - Quick Facts (RTTNews)
23.03.18	Pfizer Reports Results From Phase 4 Study With CHANTIX/CHAMPIX - Quick Facts (RTTNews)
23.03.18	Pfizer Reports Top-Line Results from a Study of CHANTIX®/CHAMPIX® (varenicline) in Adolescent Smokers (Businesswire)
23.03.18	ViiV Healthcare: CHMP Issues Positive Opinion For Juluca - Quick Facts (RTTNews)
23.03.18	GSK Withdraws From Process For Pfizer's Consumer Healthcare Unit; Stock Up (RTTNews)
22.03.18	Reckitt Benckiser Ends Discussions With Pfizer On Consumer Health Deal (RTTNews)
20.03.18	Pfizer Invites Public To View And Listen To Webcast Of May 1 Conference Call With Analysts (Businesswire)
20.03.18	ARNA Soars After-hours, Remoxy Now 2 Steps Away From Approval, APLS On Watch (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

22.11.24		Dow Jones aktuell: Dow Jones zum Ende des Freitagshandels in der Gewinnzone
22.11.24		Freundlicher Handel in New York: Dow Jones präsentiert sich am Freitagnachmittag fester
22.11.24		Börse New York in Grün: Dow Jones bewegt sich am Mittag im Plus
22.11.24		Freundlicher Handel: Börsianer lassen SPI schlussendlich steigen
22.11.24		Gute Stimmung in Europa: Anleger lassen STOXX 50 letztendlich steigen
22.11.24		Handel in Frankfurt: TecDAX letztendlich in Grün

22.11.24

Dow Jones aktuell: Dow Jones zum Ende des Freitagshandels in der Gewinnzone

22.11.24

Freundlicher Handel in New York: Dow Jones präsentiert sich am Freitagnachmittag fester

22.11.24

Börse New York in Grün: Dow Jones bewegt sich am Mittag im Plus

22.11.24

Freundlicher Handel: Börsianer lassen SPI schlussendlich steigen

22.11.24

Gute Stimmung in Europa: Anleger lassen STOXX 50 letztendlich steigen

22.11.24

Handel in Frankfurt: TecDAX letztendlich in Grün